Advanced Search
Contact | Corporate | Help

Study of Combined RHUMAB VEGF and Capecitabine-Based Chemoradiation for Patients With Locally Advanced Pancreatic Cancer

Sponsors:
  • M.D. Anderson Cancer Center
  • Genentech
Phases:
  • Phase I
IndicationsAcronym:
  • Pancreatic Cancer
Age Groups:
  • Child
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab
  • Drug: Capecitabine
  • Radiation: Radiotherapy
Enrollment:
48

Additional information about NCT00047710.


SourceSolution © 2008-2012